Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoo for dogs, cats, and horses under the Alosera trademark. The company was founded in 2001 and is based in Winnipeg, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-204-4531301
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.30 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date3/23/2020 (Estimated)
OptionableNot Optionable
Kane Biotech (CVE:KNE) Frequently Asked Questions
What is Kane Biotech's stock symbol?
Kane Biotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KNE."
When is Kane Biotech's next earnings date?
Has Kane Biotech been receiving favorable news coverage?
Press coverage about KNE stock has trended very negative this week, according to InfoTrie. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Kane Biotech earned a daily sentiment score of -3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Kane Biotech.
Who are some of Kane Biotech's key competitors?
Some companies that are related to Kane Biotech include Equillium (EQ), Biotron (BIT), Imugene (IMU), Oxford Biodynamics (OBD), Oncolytics Biotech (ONC), Sirona Biochem (SBM), Orgenesis (ORGS), Circassia Pharmaceuticals (CIR), Botanix Pharmaceuticals (BOT), Pediapharm (PDP), Verona Pharma (VRP), Promis Neurosciences (PMN), IntelGenx Technologies (IGX), Medlab Clinical (MDC) and Asterias Biotherapeutics (AST).
Who are Kane Biotech's key executives?
Kane Biotech's management team includes the folowing people:
- Mr. Marc Edwards, Interim CEO & Director
- Mr. Ray Dupuis, Chief Financial Officer
- Mr. Mark Ahrens-Townsend, Advisor
- Dr. Gordon Guay, Chief Scientific Officer & Member of Scientific Advisory Board
- Mr. L. Michael Coutts, Director of Bus. Devel.
How do I buy shares of Kane Biotech?
Shares of KNE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Kane Biotech's stock price today?
One share of KNE stock can currently be purchased for approximately C$0.18.
How big of a company is Kane Biotech?
What is Kane Biotech's official website?
How can I contact Kane Biotech?
Kane Biotech's mailing address is 162-196 Innovation Dr, WINNIPEG, MB R3T 6C5, Canada. The company can be reached via phone at +1-204-4531301.
MarketBeat Community Rating for Kane Biotech (CVE KNE)
MarketBeat's community ratings are surveys of what our community members think about Kane Biotech and other stocks. Vote "Outperform" if you believe KNE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KNE will underperform the S&P 500 over the long term. You may vote once every thirty days.
